Case Management for Crack Users Who Seek Treatment in CAPSad in Brazil
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the effectiveness of a Case Management (CM) intervention in crack users applied in Psychosocial Care Centers - Alcohol and Drugs (CAPSad) by trained social workers, in comparison to CAPSad conventional treatment on 30 and 90 days, considering the following outcomes: treatment retention, abstinence and changes in severity scores of the sixth version of Addiction Severity Index (ASI6) scale. The study hypothesis are: 1) The CM is going to improve the retention of crack users (cases) during the 3-month follow-up compared with usual care (controls); 2)Individuals who received the intervention with GC are going to present a higher rate of abstinence; 3)The summary scores of the ASI6 will be significantly lower in cases than in controls, at the end of 3 months follow-up.
| Condition | Intervention |
|---|---|
|
Crack Abuse or Dependence |
Behavioral: Case Management (Strength-Based) Behavioral: Usual Treatment |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | Effectiveness of Case Management for Crack Users Who Seek Treatment in CAPSad in Six Brazilian Capitals |
- Treatment retention [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- Crack abstinence [ Time Frame: 3 months ] [ Designated as safety issue: No ]
- ASI subareas scores [ Time Frame: 3 months ] [ Designated as safety issue: No ]ASI (Addiction Severity Index)
| Estimated Enrollment: | 600 |
| Study Start Date: | October 2011 |
| Estimated Study Completion Date: | August 2012 |
| Estimated Primary Completion Date: | August 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Case management |
Behavioral: Case Management (Strength-Based)
To improve the cases sharing between CAPSad and other health institutions and individuals and increase the strengths of the patient to cope with problems related to the crack use.
|
|
Active Comparator: Usual treatment
Usual treatment of the CAPSad
|
Behavioral: Usual Treatment
The usual treatment used for regular patients of CAPSad
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Diagnosis of crack abuse or dependence
- > 18 years old
- Initiating treatment (maximum of 1 month)
Exclusion Criteria:
- Homeless without permanent contact
- Psychotic symptoms during the intake interview
Contacts and Locations| Contact: Flavio Pechansky, PhD | 55-51-3359-7480 | fpechans@uol.com.br |
| Contact: Felix HP Kessler, PhD |
| Brazil | |
| Center for Drug and Alcohol Research (CPAD) of Federal University of Rio Grande do Sul (UFRGS) | Recruiting |
| Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 | |
| Contact: Flavio Pechansky, PhD 55-51-3359-7480 fpechans@uol.com.br | |
| Contact: Felix HP Kessler, PhD 55-51-3359-7480 kessler.ez@terra.com.br | |
| Principal Investigator: Flavio Pechansky, PhD | |
| Sub-Investigator: Felix HP Kessler, PhD | |
| Sub-Investigator: Sibele Faller, Ms | |
| Principal Investigator: | Flavio Pechansky, PhD | Center for Drug and Alcohol Research (CPAD) of Federal University of Rio Grande do Sul |
More Information
No publications provided
| Responsible Party: | Professor Flavio Pechansky, Director of Center for Drug and Alcohol Research (CPAD-UFRGS), Federal University of Rio Grande do Sul |
| ClinicalTrials.gov Identifier: | NCT01558726 History of Changes |
| Other Study ID Numbers: | 10-0176 |
| Study First Received: | March 17, 2012 |
| Last Updated: | March 17, 2012 |
| Health Authority: | Brazil: National Health Surveillance Agency |
Keywords provided by Federal University of Rio Grande do Sul:
|
Case Management Crack abuse/dependents Evaluation Inpatient |
ASI Treatment retention Abstinence |
ClinicalTrials.gov processed this record on May 23, 2013